Policy | August 04, 2021
India Initiates anti dumping probe against import of ATS-8 from China
Arch Pharma Labs has filed the application
Arch Pharma Labs has filed the application
Robust demand for the product across the Middle East, Africa and Latin America
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The highest reduction in prices for Pulse Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by importers
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Turnover of API division of ISLL stood at Rs 856.58 crore
Subscribe To Our Newsletter & Stay Updated
